Comparison of magnetic resonance whole body diffusion weighted imaging with FS-T2WI and FDG-PET/CT for initial staging and detection of lesion in newly diagnosed lymphoma

Comparison of magnetic resonance whole body diffusion weighted imaging with FS-T2WI and FDG-PET/CT for initial staging and detection of lesion in newly diagnosed lymphoma

Objective: To compare the application value of magnetic resonance whole body diffusion weighted ima-ging(MR WB-DWI) combined with FS-T2WI sequence and PET/CT in detection of disease lesion and staging in newly dia-gnosed lymphoma. Methods: A total of 25 patients with newly diagnosed lymphoma and wit...

Full description

Bibliographic Details
Main Author:	YUE Jingjing, SONG Qi, JIANG Xufeng, WANG Li, ZHAO Weili, YAN Fuhua
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Diagnostics Concepts & Practice 2021-12-01
Series:	Zhenduanxue lilun yu shijian
Subjects:	\|whole body-diffusion weighted imaging\|pet/ct\|lymphoma\|staging diagnosis
Online Access:	http://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1655187132961-1766902543.pdf

Similar Items

FDG-PET/CT in lymphoma
by: Maria M D′souza, et al.
Published: (2013-01-01)

Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma
by: Vijay Mistry, et al.
Published: (2023-01-01)

FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma
by: Andrea Gallamini, et al.
Published: (2021-08-01)

FDG-PET/CT in Lymphoma: Where Do We Go Now?
by: Yassine Al Tabaa, et al.
Published: (2021-10-01)

Prognostic value of whole-body dynamic 18F-FDG PET/CT Patlak in diffuse large B-cell lymphoma
by: Jiankang Yin, et al.
Published: (2023-09-01)

Neurolymphomatosis: Unusual Extranodal Involvement Pattern on 18F-FDG PET/CT in a Non-Hodgkin Lymphoma Recurrence
by: Marcos Pretto Mosmann, et al.
Published: (2011-04-01)

FDG PET/CT in the evaluation of a rare case of multisystem involvement in newly diagnosed Rosai–Dorfman–Destombes disease
by: Ahmed Fathala, et al.
Published: (2021-01-01)

FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects
by: Akram Al-Ibraheem, et al.
Published: (2023-02-01)

Clinical value of 18F-FDG PET/CT in the management of HIV-associated lymphoma
by: Qi Liu, et al.
Published: (2023-01-01)

FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma
by: Aino Rajamäki, et al.
Published: (2023-01-01)

Diagnostic performance of integrated whole-body 18F-FDG PET/MRI for detecting bone marrow involvement in indolent lymphoma: Comparison with 18F-FDG PET or MRI alone
by: Xuetao Chen, et al.
Published: (2023-03-01)

Comparison of 18F-FDG PET/CT and conventional methods in diagnosing extranodal natural killer/T-cell lymphoma
by: Huixia Geng, et al.
Published: (2024-01-01)

FDG-PET in mantle cell lymphoma involving skin
by: Mehmet Sönmez, et al.
Published: (2010-12-01)

Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin’s Lymphoma
by: Claudia Ortega, et al.
Published: (2023-03-01)

Prognostic Value of FDG PET/CT in Patients with Nodal Peripheral T-Cell Lymphoma
by: Woo Hee Choi, et al.
Published: (2023-09-01)

Comparison of Nasopharyngeal MR, 18 F-FDG PET/CT, and 18 F-FDG PET/MR for Local Detection of Natural Killer/T-Cell Lymphoma, Nasal Type
by: Rui Guo, et al.
Published: (2020-10-01)

Response assessment in lymphoma with PET/CT
by: J S Moller, et al.
Published: (2008-03-01)

FDG-PET/CT versus bone marrow biopsy in bone marrow involvement in newly diagnosed paediatric lymphoma: a systematic review and meta-analysis
by: Zhizhuo Li, et al.
Published: (2021-08-01)

Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients
by: Amy J. Weisman, et al.
Published: (2020-12-01)

Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT
by: William G. Breen, et al.
Published: (2022-03-01)

Whole-body magnetic resonance imaging and FDG-PET/CT for lymphoma staging: Assessment of patient experience
by: Domenico Albano, et al.
Published: (2017-12-01)

P.67 The Effects of Chemotherapy on Arterial Inflammation Assessed by ¹⁸FDG PET-CT in Patients with Lymphoma
by: Constantinos Anagnostopoulos, et al.
Published: (2020-12-01)

PET/CT in initial staging and therapy response assessment of lymphoma
by: Nagham Nabil Omar, et al.
Published: (2016-12-01)

Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using 18F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy
by: Bing Hao, et al.
Published: (2018-11-01)

FDG dose extravasations in PET/CT: frequency and impact on SUV measurements
by: Medhat M Osman, et al.
Published: (2011-11-01)

Imaging Features and Prognostic Value of FDG PET/CT in Patients with Intravascular Large B-Cell Lymphoma
by: Lim CH, et al.
Published: (2021-09-01)

Beyond lymph nodes: 18F-FDG PET/CT in detection of unusual sites of extranodal lymphoma
by: Amal Ibrahim Ahmed Othman, et al.
Published: (2019-09-01)

FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
by: Andrea Gallamini, et al.
Published: (2017-04-01)

Gallbladder Involvement of Diffuse Large B-Cell Lymphoma with 18F-FDG PET/CT
by: Esra Arslan, et al.
Published: (2022-05-01)

Unusual presentation of adrenal lymphoma observed with PET-CT
by: Zeynep Gözde Özkan, et al.
Published: (2011-12-01)

[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases
by: Laura Evangelista, et al.
Published: (2022-10-01)

Candida esophagitis incidentally detected by 18F‐FDG PET/CT in a patient with CNS lymphoma
by: Melikşah Bayar, et al.
Published: (2021-05-01)

Incremental Value of FDG PET/CT in Aggressive High Grade B Cell lymphoma with TdT Expression
by: NIKITA SAMPATHIRAO, et al.
Published: (2021-01-01)

Interest of FDG-PET in the Management of Mantle Cell Lymphoma
by: Clément Bailly, et al.
Published: (2019-04-01)

[18F]FDG-PET/CT Radiomics for Prediction of Bone Marrow Involvement in Mantle Cell Lymphoma: A Retrospective Study in 97 Patients
by: Marius E. Mayerhoefer, et al.
Published: (2020-05-01)

Assessment of Response to Immunotherapy in Patients with Hodgkin Lymphoma: Towards Quantifying Changes in Tumor Burden Using FDG-PET/CT
by: Francesca Tutino, et al.
Published: (2023-05-01)

Prediction of prognosis and pathologic grade in follicular lymphoma using 18F-FDG PET/CT
by: Hongyan Li, et al.
Published: (2022-07-01)

Prognostic significance of sequential F-FDG PET/CT during frontline treatment of peripheral T cell lymphomas
by: Ga-Young Song, et al.
Published: (2024-03-01)

The Clinical Accuracy and Risk Stratification in End of Therapy 18F-FDG PET/CT in Burkitt Lymphoma
by: Yi Wen Mo, et al.
Published: (2021-04-01)

Clinical usefulness of PET-CT in staging, evaluation of treatment response and restaging of thoracic lymphoma
by: Ahmed Elsammak
Published: (2017-12-01)